Alnylam Pharmaceuticals (ALNY) Q2 2020 Earnings

6MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-2.57
-2.32
-2.08
-1.83

Details

Expected EPS
-1.89
Actual EPS
-1.83
Surprise EPS
0.06
Surprise Percent
+3.17%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.83 per share for Q2 2020.

0 Comments

Share your thoughts